Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20195981 | 0.98 | KDM4E (0.62) | KDM4ESMN1; SMN2CYP2D6CYP2C9HIF1A | |
| SCHEMBL14022295 | 0.87 | CYP2A13 (0.55) | KDM4ESMN1; SMN2CYP2D6CYP2C9HIF1A | |
| SCHEMBL4893579 | 0.87 | ALDH1A1 (0.49) | KDM4ESMN1; SMN2ALDH1A1EPHX2NR1H4 | |
| Hydrochloric Acid SCHEMBL4900729 | 0.85 | CYP2A13 (0.54) | KDM4ESMN1; SMN2CYP2D6CYP2C9ALDH1A1 | |
| SCHEMBL12966209 | 0.82 | CXCR4 (0.47) | ALDH1A1EPHX2NR1H4ADRB2L3MBTL1 | |
| SCHEMBL24214193 | 0.82 | EPHX2 (0.45) | KDM4ESMN1; SMN2ALDH1A1EPHX2NR1H4 | |
| SCHEMBL24213985 | 0.82 | HDAC6 (0.49) | KDM4ESMN1; SMN2ALDH1A1HRH3EPHX2 | |
| SCHEMBL2933281 | 0.81 | KDM4E (0.52) | KDM4ESMN1; SMN2ALDH1A1HDAC6HDAC1 | |
| SCHEMBL2741681 | 0.81 | KDM4E (0.46) | KDM4ECYP2D6CYP2C9HIF1AALDH1A1 | |
| SCHEMBL7348167 | 0.81 | GRIN2B (0.54) | SMN1; SMN2CYP2D6CYP2C9HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210380593-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | JIANGSU HENGRUI MEDICINE CO (CN) | 2021-12-09 | — | — | US | disclosed |
| US-11117898-B2 | Pyrazolo-heteroaryl derivative, preparation method and medical use thereof | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2021-09-14 | — | — | US | disclosed |
| EP-3546457-B1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | JIANGSU HENGRUI MEDICINE CO (CN) | 2021-07-14 | — | — | EP | disclosed |
| US-20210115046-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2021-04-22 | — | — | US | disclosed |
| EP-3546457-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2019-10-02 | — | — | EP | disclosed |
| WO-2018095426-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115046-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | TLR7, TLR3, TLR4 | KDM4E 2997/4885SMN1; SMN2 4200/4885CYP2D6 128/4885 |
| US-11117898-B2 | Pyrazolo-heteroaryl derivative, preparation method and medical use thereof | TLR7, TLR3, TLR4 | KDM4E 2997/4885SMN1; SMN2 4200/4885CYP2D6 128/4885 |
| US-20210380593-A1 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | TLR7, TLR3, TLR4 | KDM4E 2997/4885SMN1; SMN2 4200/4885CYP2D6 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.